Search: onr:"swepub:oai:DiVA.org:su-60540" >
Immunological chara...
Immunological characteristics of recombinant fragments of the Plasmodium falciparum blood-stage antigen Pf332
-
- Balogun, Halima A., 1978- (author)
- Stockholms universitet,Wenner-Grens institut,Kavs Berzins, Malaria Group
-
- Berzins, Klavs, Professor (thesis advisor)
- Stockholms universitet,Wenner-Grens institut
-
- Hviid, Lars, Professor (opponent)
- University of Copenhagen, Department of international health, immunology and microbiology
-
(creator_code:org_t)
- ISBN 9789174473476
- Stockholm : The Wenner-Gren Institute, Stockholm University, 2011
- English 82 s.
- Related links:
-
https://su.diva-port... (primary) (Raw object)
-
show more...
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- Effective malaria vaccine might help improve control strategies against malaria, but the complexity of interactions between the parasite and its hosts poses challenges. The asexual blood stage P. falciparum antigen Pf332 has potentials as one of the proteins in understanding the complex host-parasite interactions. The interest in Pf332 as a target for parasite neutralizing antibodies, evolved from previous studies demonstrating that Pf332-reactive antibodies inhibits parasite growth in vitro. The presence of natural P. falciparum infection also indicated that Pf332 has the ability to induce protective antibodies. In paper I, we identified and characterized the immunogenicity of a C-terminal region of Pf332. Immunological analyses carried out with this fragment revealed that rabbit anti-C231 antibodies possess parasite in vitro inhibitory capabilities. In paper II, the functional activity of C231 specific antibodies was confirmed with human-affinity purified antibodies, where the antibodies inhibited late stage parasite development, by the presence of abnormal parasites and disintegrated red cell membranes. Epidemiological data from malaria endemic area of Senegal (Paper III & IV), showed that antibodies were reactive with two different fragments of Pf332 (C231 and DBL). Distribution of anti-C231 antibodies in the IgG subclasses, gave similar levels of IgG2 and IgG3. The levels of anti-C231 antibodies were associated with protection from clinical malaria, but with DBL reactive antibodies IgG3 was associated with protection from clinical malaria. We hereby conclude that antigen Pf332 contains immunogenic epitopes, and is a potential target for parasite neutralizing antibodies. The Pf332 protein should thus be considered as a candidate antigen for inclusion in a subunit P. falciparum malaria vaccine.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Immunology in the medical area (hsv//eng)
Keyword
- Plasmodium falciparum
- Pf332
- antibodies
- immunity
- growth inhibition
- Immunology
- Immunologi
- immunologi
- Immunology
Publication and Content Type
- vet (subject category)
- dok (subject category)
Find in a library
To the university's database